Wayne W. Grody, M.D., Ph.D.
Dr. Grody is a Professor in the Departments of Pathology & Laboratory Medicine, Pediatrics, and Human Genetics at the UCLA School of Medicine. He is the director of the Diagnostic Molecular Pathology Laboratory within the UCLA Medical Center, one of the first such facilities in the country to offer DNA-based tests for diagnosis of a wide variety of genetic, infectious, and neoplastic diseases. He is also an attending physician in the Department of Pediatrics, specializing in the care of patients with or at risk for genetic disorders. In addition, his basic molecular genetics research involves regulation of gene expression of arginase and related enzymes in hereditary arginase deficiency and various cancers and population molecular genetic screening. He has been one of the primary developers of quality assurance and ethical guidelines for DNA-based genetic testing for a number of governmental and professional agencies including the FDA, AMA, CAP, ACMG, ASHG, NCCLS, CDC, NIH-DOE Human Genome Project (ELSI program), and PSRGN. He served as a member of the NIH-DOE Task Force on Genetic Testing, and was the working group chair for development of national guidelines for cystic fibrosis and factor V-Leiden mutation screening. Most recently, he was appointed chair of an Advisory Committee on Genomic Medicine for the entire Veteran's Administration healthcare system. As a sidelight, Dr. Grody has been active in the film and television industries for many years, first as film critic for MD Magazine, a national leisure journal for physicians, then as technical advisor and sometime writer for a number of feature films, TV movies, and television series including Life Goes On, Chicago Hope, CSI, Medium, and both Nutty Professor movies. Dr. Grody received his undergraduate degree at Johns Hopkins University, his M.D. and Ph.D. degrees from Baylor College of Medicine, and completed residency and fellowship training at UCLA. He is double board-certified by the American Board of Pathology (Anatomic and Clinical Pathology, Molecular Genetic Pathology) and the American Board of Medical Genetics (Clinical Genetics, Molecular Genetics, and Biochemical Genetics).
Irving, K. Loh, M.D.
Dr. Loh is a board certified internist and subspecialty board certified cardiac specialist with an emphasis on preventive cardiology. He founded and directs the Ventura Heart Institute, which conducts education, research and preventive cardiovascular programs. Dr. Loh is a former Assistant Professor of Medicine at UCLA School of Medicine and former Assistant ClinicalProfessor of Medicine at UC Irvine. Dr. Loh received his MD from UC San Francisco, where he also did
his Internal Medicine Residency. His initial lipid research was at the National Heart, Lung and Blood Institute at the National Institutes of Health (NIH) in both intramural (Molecular Diseases/Lipid Metabolism Branch) and extramural (Cardiac Diseases Branch; Division of Heart and Vascular Diseases) divisions. He then was faculty in both Departments of Cardiology and Cardiac Surgery at Cedars-Sinai.
In private practice, he chaired the HCA Los Robles Hospital Institutional Review Board for 18years, founded the Bioethics Committee and served as its chair for 3 years, and directed theEchocardiography Laboratory for 15 years. He served as chief of medicine at the Thousand Oaks Surgical Hospital. He has been a member of Amgen’s Institutional BioSafety Committee, the State of California Department of Health Services Cardiovascular Disease Prevention Coalition,
the Manuscript Review Board and Ad Hoc Editor for the Journal of Clinical Outcomes Management, the Expert Panel on Outcomes Evaluation and Research for the American Heart Association, and an advisor to the Advisory Board Company/Cardiology Preeminence Roundtable based in Washington DC. Dr. Loh served as an Executive Steering Committee member of the West Lipid Association Board of Directors. He is a member of the Vascular Biology Working Group, the Future Forum and the Mobile Healthcare Alliance. He was the cardiovascular consultant for the SportsMed Company/Sports Club of America, appointed to the State of California Health Executive Advisory Review Team to consult on preventive cardiology, and to the Information Systems subcommittee of The Healthcare Collaborative at UCLA and Program Director for Cardiovascular Services for Community Memorial Health System. Dr. Loh was appointed to the Lumetra (previously California’s Medicare Quality Improvement Organization) Expert Panel on Acute Myocardial Infarction for hospital quality improvement, consultant for Network of Clinical Advisors LLC (NYC), MEDACorp (Boston), member of the Society of Industrial Leaders (Standard and Poor’s, NYC), Reuters Insight and Medical Advisor (heart failure) for PhereSys™ Therapeutics Corporation, and consultant physician to the Ventura County Health Care Agency
on cardiovascular disease management and development of clinical research programs. He is the principal investigator for cardiovascular trials for Westlake Medical Research (principal investigator on over 150 clinical trials in cardiovascular therapeutics). He is a charter member of Lipidologists of Los Angeles, the Doximity™ Medical Advisory Board and the HealthTap™ ClubMDand Founding Medical Expert. Since 1987 he has developed and continually refined an patientcare electronic health record program with integrated quality of care reporting.
In 1993, Dr. Loh was appointed to two White House Briefing Teams for the President’s healthcare reform proposal and served on the Executive Steering Committee of the National Health Policy Council, a bipartisan non-profit foundation chaired by Sen. Jay Rockefeller IV. He was a surrogate speaker for the White House on health care reform, lecturing nationally and regionally as well as providing interviews for newspapers, radio and television programs. He has served as a healthcare advisor for the presidential campaigns of retired General Wesley Clark, former Senator John Edwards and was a member of then-Senator Obama's Healthcare Advisory Committee.
Dr. Loh has published in the medical literature, provided articles, op-eds and interviews for magazines, newspapers, radio, television, and a column (Second Opinion) for the Star newspapers. He lectures on cardiovascular risk reduction and integrated disease management strategies for the primary and secondary prevention of heart disease (heart failure, dyslipidemias, hypertension), medical information technology to optimize quality and outcome (including presentations at UC Berkeley and Harvard Schools of Public Health) and healthcare reform. He has conducted primers for colleagues on computer presentations at regional and national speaker bureaus. He has delivered over 350 lectures, keynotes, presentations, abstracts and webcasts, including TEDx.
Scott Wade, M.S.
Mr. Wade has over 19 years experience in computer hardware and software development with associated internet applications. He earned an M.S. degree from California State University, San Jose and has held positions of increasing responsibility at Ahmdahl Corporation, Pebblesoft Learning and AOL Time Warner-Warner Music Group where he was most recenly Vice President of Technology and CTO. From 2005-2006, Mr. Wade was Chief Technology Officer at Fathom Online, a search engine marketing company focused on media strategy and search media campaign management. Mr Wade has also consulted widely as a Senior Architect in the banking, insurance, mortgage lending and healthcare industries with clients such as Ameriquest Mortgage, Digital Insight, WellPoint and Amgen. Mr. Wade has been the principal architect of IT (information technology) geographically deployed across the world, for both internal and commercial users.